Physician profile
Doris D Ling
NPI 1851338420
$1,556.85
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.24 · 2021: $31.81 · 2022: $131 · 2023: $713 · 2024: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.16 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $201.29 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $119.60 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $102.80 | 2022-2024 | Otezla, Repatha, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $94.49 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.57 | 2023-2024 | Xifaxan |
| Lilly USA, LLC | $62.08 | 2022-2024 | Mounjaro |
| Sumitomo Pharma America, INC. | $56.84 | 2023-2024 | Gemtesa |
| Almatica Pharma LLC | $44.34 | 2024 | Loreev Xr |
| Abbott Laboratories | $43.80 | 2023 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $42.74 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $39.76 | 2024 | Voquezna |
| Novo Nordisk INC | $34.36 | 2023 | Ozempic, Rybelsus, Wegovy |
| Idorsia Pharmaceuticals US INC | $27.62 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $25.68 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.47 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.67 | 2024 | Gardasil 9, Gardasil |
| Medtronic, INC. | $13.96 | 2023 | Vanta Adaptivestim |
| Novartis Pharmaceuticals Corporation | $13.38 | 2022 | |
| Si-Bone, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.